Athira Pharma, Inc. Major Shareholders & Ownership History
Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
---|---|---|---|---|---|
PERCEPTIVE ADVISORS LLC | 05/15/2025 | 5.40 M | $1.54 M | 0.00% | 13.84% |
BML CAPITAL MANAGEMENT, LLC | 05/07/2025 | 3.20 M | $911.87 K | 15.30% | 8.20% |
VANGUARD GROUP INC | 05/09/2025 | 1.54 M | $438.31 K | -1.20% | 3.94% |
SIMPLIFY ASSET MANAGEMENT INC. | 05/13/2025 | 1.49 M | $425.30 K | 0.00% | 3.82% |
PROPEL BIO MANAGEMENT, LLC | 05/15/2025 | 1.49 M | $425.30 K | 0.00% | 3.82% |
TANG CAPITAL MANAGEMENT LLC | 05/15/2025 | 600.00 K | $170.94 K | 0.00% | 1.54% |
BLACKROCK, INC. | 05/02/2025 | 457.20 K | $130.26 K | -0.34% | 1.17% |
ACADIAN ASSET MANAGEMENT LLC | 05/21/2025 | 428.53 K | $121.00 K | -1.37% | 1.10% |
BANK OF AMERICA CORP /DE/ | 05/15/2025 | 416.16 K | $118.19 K | 0.00% | 1.07% |
PATHSTONE HOLDINGS, LLC | 05/15/2025 | 372.20 K | $106.04 K | 0.00% | 0.95% |
GEODE CAPITAL MANAGEMENT, LLC | 05/13/2025 | 311.50 K | $88.77 K | -2.91% | 0.80% |
BRISTLECONE ADVISORS, LLC | 05/12/2025 | 252.20 K | $71.85 K | -25.28% | 0.65% |
QUBE RESEARCH & TECHNOLOGIES LTD | 05/15/2025 | 221.07 K | $62.98 K | -36.84% | 0.57% |
RENAISSANCE TECHNOLOGIES LLC | 05/14/2025 | 219.00 K | $62.39 K | 5.64% | 0.56% |
TWO SIGMA ADVISERS, LP | 05/15/2025 | 157.10 K | $44.76 K | -37.98% | 0.40% |
LAIRD NORTON TRUST COMPANY, LLC | 05/15/2025 | 127.31 K | $36.27 K | 0.00% | 0.33% |
STATE STREET CORP | 05/15/2025 | 107.38 K | $30.59 K | 0.00% | 0.28% |
GSA CAPITAL PARTNERS LLP | 05/08/2025 | 88.23 K | $25.00 K | -70.25% | 0.23% |
UBS GROUP AG | 05/13/2025 | 76.55 K | $21.82 K | -11.99% | 0.20% |
NORTHERN TRUST CORP | 05/13/2025 | 53.61 K | $15.27 K | 0.00% | 0.14% |
CLARIUS GROUP, LLC | 04/18/2025 | 53.55 K | $15.26 K | 0.00% | 0.14% |
INTEGRITY FINANCIAL CORP /WA | 05/12/2025 | 52.90 K | $15.07 K | 61.36% | 0.14% |
CITADEL ADVISORS LLC | 05/15/2025 | 49.57 K | $14.12 K | 100.00% | 0.13% |
XTX TOPCO LTD | 05/08/2025 | 46.15 K | $13.15 K | 160.90% | 0.12% |
INVST, LLC | 06/03/2025 | 45.00 K | $12.82 K | 0.00% | 0.12% |
EASTERLY INVESTMENT PARTNERS LLC | 05/02/2025 | 33.50 K | $9.54 K | 0.00% | 0.09% |
BRIGHTON JONES LLC | 04/17/2025 | 32.20 K | $9.17 K | 0.00% | 0.08% |
ADVISOR GROUP HOLDINGS, INC. | 05/12/2025 | 27.50 K | $7.70 K | -56.69% | 0.07% |
SIMON QUICK ADVISORS, LLC | 04/15/2025 | 20.54 K | $5.85 K | 0.00% | 0.05% |
JOURNEY STRATEGIC WEALTH LLC | 05/06/2025 | 20.54 K | $5.85 K | 0.00% | 0.05% |
BLAIR WILLIAM & CO/IL | 05/09/2025 | 20.00 K | $5.70 K | 0.00% | 0.05% |
SUSQUEHANNA INTERNATIONAL GROUP, LLP | 05/14/2025 | 18.75 K | $5.34 K | -61.95% | 0.05% |
SHAY CAPITAL LLC | 05/15/2025 | 18.59 K | $5.30 K | 57.51% | 0.05% |
CITADEL ADVISORS LLC | 05/15/2025 | 14.30 K | $4.07 K | -16.86% | 0.04% |
VANGUARD PERSONALIZED INDEXING MANAGEMENT, LLC | 05/14/2025 | 14.17 K | $4.04 K | -63.66% | 0.04% |
ROYAL BANK OF CANADA | 05/15/2025 | 14.15 K | $4.00 K | -92.27% | 0.04% |
HRT FINANCIAL LP | 05/15/2025 | 14.08 K | $4.00 K | -67.07% | 0.04% |
HIGHTOWER ADVISORS, LLC | 05/13/2025 | 12.70 K | $3.62 K | 0.00% | 0.03% |
ENGINEERS GATE MANAGER LP | 05/15/2025 | 11.04 K | $3.15 K | -32.91% | 0.03% |
PRELUDE CAPITAL MANAGEMENT, LLC | 05/15/2025 | 11.00 K | $3.13 K | 0.00% | 0.03% |
TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2025 | 9.55 K | $2.72 K | -28.71% | 0.02% |
LINDBROOK CAPITAL, LLC | 05/05/2025 | 8.92 K | $2.54 K | 0.00% | 0.02% |
MORGAN STANLEY | 05/15/2025 | 5.11 K | $1.46 K | -14.97% | 0.01% |
CITADEL ADVISORS LLC | 05/15/2025 | 4.40 K | $1.25 K | 450.00% | 0.01% |
COLDSTREAM CAPITAL MANAGEMENT INC | 05/13/2025 | 2.64 K | $753 | 100.00% | 0.01% |
AMERICAN CAPITAL ADVISORY, LLC | 04/28/2025 | 2.00 K | $570 | 0.00% | 0.01% |
ROTHSCHILD INVESTMENT LLC | 04/08/2025 | 1.50 K | $427 | 0.00% | 0.00% |
BNP PARIBAS ARBITRAGE, SNC | 05/14/2025 | 1.36 K | $388 | 0.00% | 0.00% |
FEDERATED HERMES, INC. | 05/08/2025 | 831 | $237 | -18.05% | 0.00% |
MCILRATH & ECK, LLC | 05/16/2025 | 825 | $235 | 0.00% | 0.00% |
Athira Pharma, Inc. institutional Ownership - FAQ's
During the previous two years, 68 institutional investors and hedge funds held shares of Athira Pharma, Inc.. The most heavily invested institutionals were:
PERCEPTIVE ADVISORS LLC: 5.4 M
BML Capital Management, LLC: 3.2 M
VANGUARD GROUP INC: 1.54 M
Simplify Asset Management Inc.: 1.49 M
Propel Bio Management, LLC: 1.49 M
TANG CAPITAL MANAGEMENT LLC: 600,000
44.99% of Athira Pharma, Inc. stock is owned by institutional investors.
Institutional investors have bought a total of 19.08 M shares in the last 24 months. This purchase volume represents approximately $7.63 M in transactions.